---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-020003"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2023-05-10T23:59:59+00:00"
generated_at: "2026-06-15T06:54:24.581829+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GoodRx Q1 revenue $184M beats guidance; adjusted EBITDA $53.2M

## Summary
- Revenue $184.0M exceeds guidance; adjusted EBITDA $53.2M (28.9% margin) also above range.
- Net loss $3.3M includes $25.5M stock-based comp; adjusted net income $29.5M (16.0% margin).
- Scott Wagner appointed Interim CEO; Trevor Bezdek remains Chairman; leadership aims to accelerate growth.
- Over 450,000 prescribers engaged via Provider Mode; over 7M consumers of prescription offerings.
- Operating cash flow $32.3M in Q1 2023.

## SEC filing metadata
- accession: 0000950170-23-020003
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2023-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000095017023020003/0000950170-23-020003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000095017023020003/gdrx-20230510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-020003
- JSON: https://secwatch.observer/filing/0000950170-23-020003.json
- Plain text: https://secwatch.observer/filing/0000950170-23-020003.txt

## Key facts
- Earnings Releases
  GoodRx Holdings, Inc. reported the three months ended March 31, 2023 results: revenue $184.0 million, net income $3.3 million.
  - Period: the three months ended March 31, 2023
  - Revenue: $184.0 million
  - Net income: $3.3 million
  - Result: reported results
  source text: or the “Company”) , a leading digital healthcare platform, has released its financial results for the first quarter 2023. First Quarter 2023 Highlights • Total revenue of $184.0 million, exceeding previously announced guidance • Net loss of $3.3 million 1 ; Net loss margin of 1.8% • Adjusted Net Income 2 of $29.5 million; Adjusted Net Income Margin 2 of 16.0% •
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000095017023020003/0000950170-23-020003-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.